Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Researchers from the Cancer Research UK Scotland Institute in Glasgow have discovered why certain cancer-causing genes ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

Blocking Caspase-2 (the liver’s guardian enzyme) to treat fatty liver may produce chronic damage and multiply the risk of ...

Patients who survive colorectal cancer face a sustained and increased risk of death from chronic liver disease and cirrhosis long after surgery, according to a large population-based analysis from the ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Researchers have discovered new treatments to suppress the growth of cancers of the bowel and liver. Researchers at the ...

Cytotheryx, a preclinical cell therapy company developing treatments for liver disease, is receiving $60 million in Series A ...

Learn how weight loss, diet changes and regular exercise can help manage — and sometimes reverse — fatty liver disease when ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Are you a late-night snack lover? Well, researchers at the University of Oxford have discovered that the most common liver ...